Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-011777
Filing Date
2022-05-02
Accepted
2022-05-02 15:55:16
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10ka.htm   iXBRL 10-K/A 384435
2 ex31-1.htm EX-31.1 4683
3 ex31-2.htm EX-31.2 4717
  Complete submission text file 0001493152-22-011777.txt   664129

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcsa-20211231.xsd EX-101.SCH 3078
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcsa-20211231_lab.xml EX-101.LAB 36496
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcsa-20211231_pre.xml EX-101.PRE 24028
8 EXTRACTED XBRL INSTANCE DOCUMENT form10ka_htm.xml XML 6981
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39531 | Film No.: 22881740
SIC: 2834 Pharmaceutical Preparations